Results 271 to 280 of about 169,585 (295)

What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?

World Psychiatry, 2018
Christoph U Correll, Jose M Rubio, John M Kane   +2 more
exaly  

Antipsychotics

Reactions Weekly, 1995
openaire   +1 more source

Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial

Lancet, The, 2014
Douglas Turkington, Melissa Pyle, Graham Dunn   +2 more
exaly  

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

New England Journal of Medicine, 2005
Jeffrey A Lieberman, Robert Alan Rosenheck, Barry D Lebowitz   +2 more
exaly  

Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations

Nature Reviews Drug Discovery, 2006
Jeffrey A Lieberman
exaly  

Antipsychotics

Reactions Weekly, 2014
openaire   +2 more sources

Antipsychotics

Reactions Weekly, 2022
openaire   +1 more source

Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism

Lancet, The, 2002
Gavin P Reynolds
exaly  

Antipsychotics

2010
openaire   +1 more source

Antipsychotics

Reactions Weekly, 2017
openaire   +1 more source